These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37915239)

  • 1. Targeted degradation of SNCA/α-synuclein aggregates in neurodegeneration using the AUTOTAC chemical platform.
    Lee J; Yoon D; Sung KW; Bae EJ; Park DH; Suh YH; Kwon YT
    Autophagy; 2024 Feb; 20(2):463-465. PubMed ID: 37915239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted degradation of ⍺-synuclein aggregates in Parkinson's disease using the AUTOTAC technology.
    Lee J; Sung KW; Bae EJ; Yoon D; Kim D; Lee JS; Park DH; Park DY; Mun SR; Kwon SC; Kim HY; Min JO; Lee SJ; Suh YH; Kwon YT
    Mol Neurodegener; 2023 Jun; 18(1):41. PubMed ID: 37355598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera).
    Ji CH; Lee MJ; Kim HY; Heo AJ; Park DY; Kim YK; Kim BY; Kwon YT
    Autophagy; 2022 Sep; 18(9):2259-2262. PubMed ID: 35722947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperine promotes autophagy flux by P2RX4 activation in
    Li R; Lu Y; Zhang Q; Liu W; Yang R; Jiao J; Liu J; Gao G; Yang H
    Autophagy; 2022 Mar; 18(3):559-575. PubMed ID: 34092198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.
    Prieto Huarcaya S; Drobny A; Marques ARA; Di Spiezio A; Dobert JP; Balta D; Werner C; Rizo T; Gallwitz L; Bub S; Stojkovska I; Belur NR; Fogh J; Mazzulli JR; Xiang W; Fulzele A; Dejung M; Sauer M; Winner B; Rose-John S; Arnold P; Saftig P; Zunke F
    Autophagy; 2022 May; 18(5):1127-1151. PubMed ID: 35287553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy mediates the clearance of oligodendroglial SNCA/alpha-synuclein and TPPP/p25A in multiple system atrophy models.
    Mavroeidi P; Arvanitaki F; Vetsi M; Becker S; Vlachakis D; Jensen PH; Stefanis L; Xilouri M
    Autophagy; 2022 Sep; 18(9):2104-2133. PubMed ID: 35000546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
    Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
    Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system.
    Ji CH; Kim HY; Lee MJ; Heo AJ; Park DY; Lim S; Shin S; Ganipisetti S; Yang WS; Jung CA; Kim KY; Jeong EH; Park SH; Bin Kim S; Lee SJ; Na JE; Kang JI; Chi HM; Kim HT; Kim YK; Kim BY; Kwon YT
    Nat Commun; 2022 Feb; 13(1):904. PubMed ID: 35173167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MANF Inhibits
    Zhang JX; Tong WF; Jiang M; Zhou KG; Xiang XR; He YJ; Zhang ZY; Guan Q; Jin LJ
    Oxid Med Cell Longev; 2022; 2022():7925686. PubMed ID: 35847585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons.
    Burbidge K; Rademacher DJ; Mattick J; Zack S; Grillini A; Bousset L; Kwon O; Kubicki K; Simon A; Melki R; Campbell EM
    Autophagy; 2022 May; 18(5):1020-1048. PubMed ID: 34612142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype.
    Minakaki G; Menges S; Kittel A; Emmanouilidou E; Schaeffner I; Barkovits K; Bergmann A; Rockenstein E; Adame A; Marxreiter F; Mollenhauer B; Galasko D; Buzás EI; Schlötzer-Schrehardt U; Marcus K; Xiang W; Lie DC; Vekrellis K; Masliah E; Winkler J; Klucken J
    Autophagy; 2018; 14(1):98-119. PubMed ID: 29198173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to detect AUTOphagy-Targeting Chimera (AUTOTAC)-mediated Targeted Protein Degradation in Tauopathies.
    Lee MJ; Kim SB; Kim HY; Lee SJ; Lee JS; Kwon YT; Ji CH
    Bio Protoc; 2023 Jan; 13(2):e4594. PubMed ID: 36789169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synucleinphagy: a microglial "community cleanup program" for neuroprotection.
    Choi I; Seegobin SP; Liang D; Yue Z
    Autophagy; 2020 Sep; 16(9):1718-1720. PubMed ID: 32453651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing INS-IGF1 signaling protects against non-cell autonomous vesicle rupture caused by SNCA spreading.
    Sandhof CA; Hoppe SO; Druffel-Augustin S; Gallrein C; Kirstein J; Voisine C; Nussbaum-Krammer C
    Autophagy; 2020 May; 16(5):878-899. PubMed ID: 31354022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clustering lysosomes around the MTOC: a promising strategy for SNCA/alpha-synuclein breakdown leading to parkinson disease treatment.
    Sasazawa Y; Date Y; Hattori N; Saiki S
    Autophagy; 2024 Dec; 20(12):2839-2840. PubMed ID: 39401987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LAMP2A as a therapeutic target in Parkinson disease.
    Xilouri M; Brekk OR; Kirik D; Stefanis L
    Autophagy; 2013 Dec; 9(12):2166-8. PubMed ID: 24145820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acidic nanoparticles protect against α-synuclein-induced neurodegeneration through the restoration of lysosomal function.
    Arotcarena ML; Soria FN; Cunha A; Doudnikoff E; Prévot G; Daniel J; Blanchard-Desce M; Barthélémy P; Bezard E; Crauste-Manciet S; Dehay B
    Aging Cell; 2022 Apr; 21(4):e13584. PubMed ID: 35318803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urate promotes SNCA/α-synuclein clearance via regulating mTOR-dependent macroautophagy.
    Sheng YL; Chen X; Hou XO; Yuan X; Yuan BS; Yuan YQ; Zhang QL; Cao X; Liu CF; Luo WF; Hu LF
    Exp Neurol; 2017 Nov; 297():138-147. PubMed ID: 28821398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson's Disease.
    Xu Y; Zhang Y; Quan Z; Wong W; Guo J; Zhang R; Yang Q; Dai R; McGeer PL; Qing H
    Neurochem Res; 2016 Oct; 41(10):2788-2796. PubMed ID: 27364962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.